132 related articles for article (PubMed ID: 36039427)
1. Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma.
Li CH; Ku MC; Lee KC; Yueh PF; Hsu FT; Lin RF; Yang CC; Wang WC; Chen JH; Hsu LC; Lee YH
Anticancer Res; 2022 Sep; 42(9):4403-4410. PubMed ID: 36039427
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
3. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
Su CM; Weng YS; Kuan LY; Chen JH; Hsu FT
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429376
[TBL] [Abstract][Full Text] [Related]
4. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells.
Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS
In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689
[TBL] [Abstract][Full Text] [Related]
5. Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells.
Lee YC; Weng YS; Wang HY; Hsu FT; Chueh FS; Wu JY; Chen WL; Chen JH
Anticancer Res; 2022 Aug; 42(8):3825-3833. PubMed ID: 35896265
[TBL] [Abstract][Full Text] [Related]
6. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
7. Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis.
Hsu FT; Liu WL; Lee SR; Jeng LB; Chen JH
Phytomedicine; 2023 Oct; 119():154947. PubMed ID: 37549536
[TBL] [Abstract][Full Text] [Related]
8. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.
Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z
J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653
[TBL] [Abstract][Full Text] [Related]
9. Magnolol inhibits tumor necrosis factor-α-induced ICAM-1 expression via suppressing NF-κB and MAPK signaling pathways in human lung epithelial cells.
Chunlian W; Heyong W; Jia X; Jie H; Xi C; Gentao L
Inflammation; 2014 Dec; 37(6):1957-67. PubMed ID: 24893579
[TBL] [Abstract][Full Text] [Related]
10. Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response.
Luo J; Xu Y; Zhang M; Gao L; Fang C; Zhou C
Inflammation; 2013 Oct; 36(5):997-1003. PubMed ID: 23515857
[TBL] [Abstract][Full Text] [Related]
11. Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB.
Su CM; Li CH; Huang MC; Yueh PF; Hsu FT; Lin RF; Hsu LC
In Vivo; 2022; 36(3):1136-1143. PubMed ID: 35478108
[TBL] [Abstract][Full Text] [Related]
12. Magnolol attenuates the inflammation and enhances phagocytosis through the activation of MAPK, NF-κB signal pathways in vitro and in vivo.
Chen H; Fu W; Chen H; You S; Liu X; Yang Y; Wei Y; Huang J; Rui W
Mol Immunol; 2019 Jan; 105():96-106. PubMed ID: 30500626
[TBL] [Abstract][Full Text] [Related]
13. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.
Pan PJ; Tsai JJ; Liu YC
Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib Induces Apoptosis and Inhibits NF-κB-mediated Anti-apoptotic and Metastatic Potential in Osteosarcoma Cells.
Wu CH; Lin KH; Fu BS; Hsu FT; Tsai JJ; Weng MC; Pan PJ
Anticancer Res; 2021 Mar; 41(3):1251-1259. PubMed ID: 33788716
[TBL] [Abstract][Full Text] [Related]
15. Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
Zhang FH; Ren HY; Shen JX; Zhang XY; Ye HM; Shen DY
Biomed Pharmacother; 2017 Oct; 94():474-480. PubMed ID: 28779709
[TBL] [Abstract][Full Text] [Related]
16. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
17. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
18. Magnolol reduced TNF-α-induced vascular cell adhesion molecule-1 expression in endothelial cells via JNK/p38 and NF-κB signaling pathways.
Liang CJ; Lee CW; Sung HC; Chen YH; Wang SH; Wu PJ; Chiang YC; Tsai JS; Wu CC; Li CY; Chen YL
Am J Chin Med; 2014; 42(3):619-37. PubMed ID: 24871655
[TBL] [Abstract][Full Text] [Related]
19. The
Chen YS; Sun R; Chen WL; Yau YC; Hsu FT; Chung JG; Tsai CJ; Hsieh CL; Chiu YM; Chen JH
In Vivo; 2020; 34(4):1789-1796. PubMed ID: 32606148
[TBL] [Abstract][Full Text] [Related]
20. Magnolol Reduces Renal Ischemia and Reperfusion Injury via Inhibition of Apoptosis.
Tang CY; Lai CC; Huang PH; Yang AH; Chiang SC; Huang PC; Tseng KW; Huang CH
Am J Chin Med; 2017; 45(7):1421-1439. PubMed ID: 28946769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
